「to」の検索結果
424件：341～345件目を表示
-
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eye
https://www.senju.co.jp/english/rd/pipeline.html -
千寿製薬について | 千寿製薬株式会社
CEO Message Management Policy Company Profile Our Initiatives for Society / Environment Business Activities Production system Quality policy
https://www.senju.co.jp/english/about/ -
お知らせ | 千寿製薬株式会社
or Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibition（PDF） September 4, 2025 Senju has develo...
https://www.senju.co.jp/english/news/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
ts of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Minoru Kanamoto, MSc; Kazunori Omatsu, BSc AAO 2025 開催日：2025年10月17日～2025年10月20日 ...
https://www.senju.co.jp/english/rd/society/ -
お知らせ | 千寿製薬株式会社
https://www.senju.co.jp/english/news/javascipt: void(0);